Altrinsic Global Advisors LLC Surface Oncology, Inc. Transaction History

Altrinsic Global Advisors LLC

  • $2.15 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 14, 2019
SELL
$4.11 - $5.88 $657,920 - $941,258
-160,078 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$3.65 - $10.69 $36,784 - $107,733
10,078 Added 6.72%
160,078 $679,000
Q3 2018

Nov 14, 2018
BUY
$8.92 - $17.83 $977,640 - $1.95 Million
109,601 Added 271.3%
150,000 $1.64 Million
Q2 2018

Aug 13, 2018
BUY
$12.83 - $17.41 $518,319 - $703,346
40,399 New
40,399 $659,000

Others Institutions Holding SURF

# of Institutions
2
Shares Held
315K
Call Options Held
0
Put Options Held
0
View Full List

About Surface Oncology, Inc.

SURF Quotes by TradingView
  • Ticker SURF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,034,000
  • Description
  • Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...
More about SURF
Track This Portfolio

Track Altrinsic Global Advisors LLC Portfolio

Follow Altrinsic Global Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altrinsic Global Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email